OA12316A - 3-Aminoquinazolin-2,4-dione antibacterial agents. - Google Patents

3-Aminoquinazolin-2,4-dione antibacterial agents. Download PDF

Info

Publication number
OA12316A
OA12316A OA1200200210A OA1200200210A OA12316A OA 12316 A OA12316 A OA 12316A OA 1200200210 A OA1200200210 A OA 1200200210A OA 1200200210 A OA1200200210 A OA 1200200210A OA 12316 A OA12316 A OA 12316A
Authority
OA
OAPI
Prior art keywords
amino
dione
cyclopropyl
fluoro
quinazoline
Prior art date
Application number
OA1200200210A
Other languages
English (en)
Inventor
Paul Bird
Edmund Lee Ellsworth
Dai Quoc Nguyen
Joseph Peter Sanchez
Howard Daniel Hollis Showalter
Rajeshwar Singh
Michael Andrew Stier
Tuan Phong Tran
Brian Morgan Watson
Judy Yip
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of OA12316A publication Critical patent/OA12316A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paper (AREA)
OA1200200210A 2000-01-24 2000-12-12 3-Aminoquinazolin-2,4-dione antibacterial agents. OA12316A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17825200P 2000-01-24 2000-01-24
US24126700P 2000-10-18 2000-10-18

Publications (1)

Publication Number Publication Date
OA12316A true OA12316A (en) 2006-05-15

Family

ID=26874138

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200200210A OA12316A (en) 2000-01-24 2000-12-12 3-Aminoquinazolin-2,4-dione antibacterial agents.

Country Status (38)

Country Link
US (2) US7094780B1 (pl)
EP (1) EP1255739B1 (pl)
JP (1) JP4811978B2 (pl)
KR (1) KR20020067701A (pl)
CN (1) CN1425008A (pl)
AP (1) AP2002002603A0 (pl)
AR (1) AR030186A1 (pl)
AT (1) ATE398110T1 (pl)
AU (1) AU783078B2 (pl)
BG (1) BG107023A (pl)
BR (1) BR0017010A (pl)
CA (1) CA2393802C (pl)
CO (1) CO5320600A1 (pl)
CR (1) CR6709A (pl)
DE (1) DE60039194D1 (pl)
EA (1) EA005585B1 (pl)
EE (1) EE200200412A (pl)
ES (1) ES2304992T3 (pl)
GE (1) GEP20053429B (pl)
HK (1) HK1054237A1 (pl)
HN (1) HN2001000009A (pl)
HR (1) HRP20020696A2 (pl)
HU (1) HUP0204101A3 (pl)
IL (1) IL150393A0 (pl)
IS (1) IS6448A (pl)
MA (1) MA26866A1 (pl)
MX (1) MXPA02005989A (pl)
NO (1) NO20023516D0 (pl)
OA (1) OA12316A (pl)
PA (1) PA8510101A1 (pl)
PE (1) PE20011060A1 (pl)
PL (1) PL356837A1 (pl)
SK (1) SK10572002A3 (pl)
SV (1) SV2001000288A (pl)
TN (1) TNSN01011A1 (pl)
UY (1) UY26551A1 (pl)
WO (1) WO2001053273A1 (pl)
YU (1) YU55902A (pl)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK286420B6 (sk) 1997-09-15 2008-09-05 The Procter & Gamble Company Zlúčenina so štruktúrou chinolónu, farmaceutický prostriedok s jej obsahom a jej použitie
JP2004532876A (ja) 2001-05-30 2004-10-28 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 抗菌剤
EP1401830A2 (en) * 2001-06-19 2004-03-31 Warner-Lambert Company LLC Quinazolinediones as antibacterial agents
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
WO2005026153A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinazoline-2, 4-diones as antibacterial agents
JP2007505096A (ja) * 2003-09-12 2007-03-08 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー キノロン抗菌剤
EP1687296A1 (en) * 2003-11-18 2006-08-09 Warner-Lambert Company LLC Antibacterial aminoquinazolidinedione derivatives
WO2006019965A2 (en) * 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
ATE447572T1 (de) * 2005-01-26 2009-11-15 Hoffmann La Roche Phenylmethanonderivate und ihre verwendung als glycin-transporter-1-hemmer
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7977346B2 (en) 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
MX2008012488A (es) 2006-03-28 2008-10-10 Procter & Gamble Un proceso de acoplamiento para preparar intermedios de quinolona.
EP2001862B1 (en) 2006-03-28 2011-04-27 Warner Chilcott Company, LLC Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
PT2239257E (pt) * 2008-01-30 2012-09-12 Shin Poong Pharmaceutical Co Ltd Novo derivado de quinazolina-2,4-diona e composições médicas para a profilaxia e tratamento da doença dos nervos cranianos contendo o dito derivado
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
US8754114B2 (en) 2010-12-22 2014-06-17 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
EP2686320B1 (en) 2011-03-15 2016-05-18 Merck Sharp & Dohme Corp. Tricyclic gyrase inhibitors
PT2796460T (pt) * 2011-12-21 2018-11-05 Shanghai hengrui pharmaceutical co ltd Derivado pirrole de anel heteroarilo de seis membros, método de preparação do mesmo e suas utilizações médicas
RS58514B1 (sr) 2012-06-13 2019-04-30 Incyte Holdings Corp Supstituisana triciklična jedinjenja kao inhibitori fgfr
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
CN105189505B (zh) 2012-09-12 2019-03-22 默克夏普&多梅有限公司 用作抗菌剂的三环促旋酶抑制剂
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
PH12015502383B1 (en) 2013-04-19 2023-02-03 Incyte Holdings Corp Bicyclic heterocycles as fgfr inhibitors
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
TWI712601B (zh) 2015-02-20 2020-12-11 美商英塞特公司 作為fgfr抑制劑之雙環雜環
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
CN108530448A (zh) * 2017-03-02 2018-09-14 浙江司太立制药股份有限公司 含有碱性氮杂螺环片段的苯并噻嗪-4-酮类化合物及其制备方法
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
HRP20241288T1 (hr) 2018-05-04 2024-12-06 Incyte Corporation Čvrsti oblici fgfr inhibitora i postupci za njihovu proizvodnju
AU2019262579B2 (en) 2018-05-04 2024-09-12 Incyte Corporation Salts of an FGFR inhibitor
CN111620866A (zh) * 2019-02-27 2020-09-04 南京药石科技股份有限公司 一种顺式-7,7-二氟-六氢-1H 吡咯并[3,4-c]吡啶衍生物及其制备方法
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2021067374A1 (en) 2019-10-01 2021-04-08 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
CA3157361A1 (en) 2019-10-14 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
JP7832891B2 (ja) 2019-12-04 2026-03-18 インサイト・コーポレイション Fgfr阻害剤の誘導体
CA3163875A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
CN111499513B (zh) * 2020-04-24 2023-03-14 上海毕得医药科技股份有限公司 一种2,3,4,5-四溴苯甲酸酯的合成方法
WO2022221170A1 (en) 2021-04-12 2022-10-20 Incyte Corporation Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
US11939331B2 (en) 2021-06-09 2024-03-26 Incyte Corporation Tricyclic heterocycles as FGFR inhibitors
CA3220155A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068263B (pl) * 1959-11-05
FR1203542A (fr) * 1958-02-25 1960-01-19 Rhone Poulenc Sa Nouveaux dérivés de la phénothiazine comportant en position 10 une chaîne pipérazinique et leurs procédés de préparation
EP0035619B1 (fr) 1980-03-10 1984-07-25 BERRI-BALZAC Société dite: Dérivés d'amino-3 (1H,3H) quinazolinedione-2,4
GB2097784A (en) 1981-04-28 1982-11-10 Davidson Dr John Stirton Dihydrobenzotriazepine diones; aminoquinazoline diones
WO1994014809A1 (de) 1992-12-23 1994-07-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Anellierte uracilderivate
WO1998018781A2 (en) 1996-10-28 1998-05-07 Versicor, Inc. Fused 2,4-pyrimidinedione combinatorial libraries, their preparation and the use of fused 2,4-pyrimidinediones derivatives as antimicrobial agents
DK1028950T3 (da) * 1997-10-28 2003-09-01 Warner Lambert Co 7-substituerede quinazolin-2,4-dioner nyttige som antibakterielle midler
TR200003429T2 (tr) 1998-05-26 2001-07-23 Warner-Lambert Company Hücresel çoğalma inhibitörleri olarak bisiklik pirimidinler ve bisiklik 3,4-dihidropirimidinler.
AU765729B2 (en) * 1998-12-11 2003-09-25 F. Hoffmann-La Roche Ag Cyclic hydrazine derivatives as TNF-alpha inhibitors

Also Published As

Publication number Publication date
EP1255739A1 (en) 2002-11-13
HUP0204101A3 (en) 2004-05-28
YU55902A (sh) 2006-01-16
GEP20053429B (en) 2005-01-25
CO5320600A1 (es) 2003-09-30
JP2003520277A (ja) 2003-07-02
HK1054237A1 (zh) 2003-11-21
TNSN01011A1 (en) 2005-11-10
US20060183762A1 (en) 2006-08-17
MXPA02005989A (es) 2002-10-23
US7094780B1 (en) 2006-08-22
US20060287308A1 (en) 2006-12-21
HUP0204101A2 (hu) 2003-04-28
HRP20020696A2 (en) 2003-12-31
BR0017010A (pt) 2002-11-05
EP1255739B1 (en) 2008-06-11
MA26866A1 (fr) 2004-12-20
US7582627B2 (en) 2009-09-01
CN1425008A (zh) 2003-06-18
CR6709A (es) 2003-11-25
ATE398110T1 (de) 2008-07-15
WO2001053273A1 (en) 2001-07-26
NO20023516L (no) 2002-07-23
IL150393A0 (en) 2002-12-01
EE200200412A (et) 2003-10-15
AU2089901A (en) 2001-07-31
KR20020067701A (ko) 2002-08-23
CA2393802A1 (en) 2001-07-26
AR030186A1 (es) 2003-08-13
NO20023516D0 (no) 2002-07-23
HN2001000009A (es) 2001-06-13
JP4811978B2 (ja) 2011-11-09
CA2393802C (en) 2011-04-19
ES2304992T3 (es) 2008-11-01
AP2002002603A0 (en) 2002-09-30
PL356837A1 (pl) 2004-07-12
EA200200661A1 (ru) 2003-02-27
PA8510101A1 (es) 2003-06-30
BG107023A (en) 2003-04-30
PE20011060A1 (es) 2001-10-12
EA005585B1 (ru) 2005-04-28
AU783078B2 (en) 2005-09-22
UY26551A1 (es) 2001-04-30
IS6448A (is) 2002-06-27
SV2001000288A (es) 2001-11-30
SK10572002A3 (sk) 2003-10-07
DE60039194D1 (de) 2008-07-24

Similar Documents

Publication Publication Date Title
OA12316A (en) 3-Aminoquinazolin-2,4-dione antibacterial agents.
RS55902B1 (sr) Obujmica za crevo
JPH0819099B2 (ja) アザビシクロキノロンカルボン酸化合物製造用中間体
HU196986B (en) Process for producing new naphtiridine- and quinoline-carboxylic acids of antibacterial activity and pharmaceutical compositions containing them
EP1028950B1 (en) 7-substituted quinazolin-2,4-diones useful as antibacterial agents
EP3080131A1 (en) Imidazopyridazine compounds useful as modulators of il-12, il-23 and/or ifn alpha responses
JP2003026574A (ja) 抗バクテリア剤
NZ243214A (en) 7-isoindolino-quinolone and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions
AU748749B2 (en) Isoquinolones
CZ190393A3 (en) Derivatives of 7-isoindolinylquinoline and 7-isoindolinylnaphthhydridone
JPS61243077A (ja) 抗菌剤
HU219581B (hu) Új piridon-karbonsav-származékok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
EP0362759A1 (en) Pyridonecarboxylic acids
US20030114666A1 (en) Antibacterial agents
WO1995021163A1 (en) Pyridonecarboxylic acid derivative substituted by bicyclic amino group, ester thereof, salt thereof, and bicyclic amine as intermediate therefor
EP0347851A1 (en) Quinolonecarboxylic acids
JPH037260A (ja) 新規キノロン誘導体またはその塩及びこれを含有する抗菌剤
JP3951136B2 (ja) 新規ピリドンカルボン酸誘導体又はその塩並びに該物質を有効成分とする抗菌剤
JP4009874B2 (ja) 新規ピリドンカルボン酸誘導体又はその塩並びに該物質を有効成分とする抗菌剤
JPWO1996012704A1 (ja) 新規ピリドンカルボン酸誘導体又はその塩並びに該物質を有効成分とする抗菌剤